Advertisement

Topics

VaxGen, Inc. Company Profile

19:53 EST 15th December 2018 | BioPortfolio


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

To evaluate the safety and immunogenicity of SF-2 rgp120 vaccine in MF59 versus MN rgp120 vaccine in alum in volunteers who are seronegative for HIV-1. AS PER AMENDMENT 07/02/97: To determ...

Companies [3 Associated Companies listed on BioPortfolio]

VaxGen Incorporated

VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the technology necessary for completing development and ...

VaxGen Inc.

VaxGen Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Founded in 1...

VaxGen, Inc.

More Information about "VaxGen, Inc." on BioPortfolio

We have published hundreds of VaxGen, Inc. news stories on BioPortfolio along with dozens of VaxGen, Inc. Clinical Trials and PubMed Articles about VaxGen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VaxGen, Inc. Companies in our database. You can also find out about relevant VaxGen, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record